Home LiteratureArticle Details
PMID: 20506119 Published · ppublish English Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

EGR1, EGR2, and EGR3 activate the expression of their coregulator NAB2 establishing a negative feedback loop in cells of neuroectodermal and epithelial origin.

Journal of cellular biochemistry ·Vol. 111 ·No. 1 ·2010-09-01 ·Pages 207-17

Kumbrink J, Kirsch KH, Johnson JP

Abstract

The inducible zinc finger transcription factors EGR1, EGR2, and EGR3 regulate the expression of numerous genes involved in differentiation, growth, and response to extracellular signals. Their activity is modulated in part through NAB2 which is induced by the same stimuli. In melanoma and carcinoma cells EGR1 activates NAB2 expression. In T lymphocytes EGR2 and EGR3 have been shown to inhibit NAB2 expression. Therefore, we investigated the influence of EGR2 and EGR3 on NAB2 expression in melanoma and carcinoma cells. Here, we show that like EGR1, EGR2 and EGR3 induced NAB2 expression in these cells. EGR1 and EGR3 act in concert on the NAB2 promoter and are more potent activators of NAB2 transcription than EGR2. EGR1-, EGR2-, and EGR3-induced NAB2 promoter activity is mediated through similar cis-regulatory elements and the activation by each EGR is repressed by NAB2. Kinetic studies suggest that induction of EGR1 leads to low NAB2 expression, while EGR2 and EGR3 are necessary for maximal and sustained expression. As already shown for EGR1, reduction of EGR2 or EGR3 expression by siRNAs reduced endogenous NAB2 levels. Depletion of EGR3 also resulted in a reduction of EGR2 levels confirming EGR2 as a target gene of EGR3. Our results suggest that in many cells of neuroectodermal and epithelial origin EGR1, EGR2, and EGR3 activate NAB2 transcription which is in turn repressed by NAB2, thus establishing a negative feedback loop. This points to a complex relationship between the EGR factors and NAB2 expression likely depending on the cellular context.

MeSH Terms
Animals Cell Line, Tumor Early Growth Response Protein 1/genetics,metabolism Early Growth Response Protein 2/genetics,metabolism Early Growth Response Protein 3/genetics,metabolism Epithelial Cells/cytology,physiology Feedback, Physiological/physiology Gene Expression Regulation Humans Neural Plate/cytology Promoter Regions, Genetic RNA, Small Interfering/genetics,metabolism Repressor Proteins/genetics,metabolism T-Lymphocytes/cytology,physiology Transcription, Genetic
Chemicals
EGR1 protein, human EGR2 protein, human EGR3 protein, human Early Growth Response Protein 1 Early Growth Response Protein 2 NAB2 protein, human RNA, Small Interfering Repressor Proteins Early Growth Response Protein 3
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Kumbrink Joerg
Institute for Immunology, University of Munich, Munich 80336, Germany.
Kirsch Kathrin H
Johnson Judith P
References (40)
40 references, click to expand
  1. EGR2 induces apoptosis in various cancer cell lines by direct transactivation of BNIP3L and BAK.
    Oncogene. 2003 Apr 10;22(14):2172-85 PMID: 12687019
  2. Cutting Edge: TCR-induced NAB2 enhances T cell function by coactivating IL-2 transcription.
    J Immunol. 2006 Dec 15;177(12):8301-5 PMID: 17142725
  3. A novel activation function for NAB proteins in EGR-dependent transcription of the luteinizing hormone beta gene.
    J Biol Chem. 2000 Mar 31;275(13):9749-57 PMID: 10734128
  4. The zinc-finger transcription factor, early growth response 3, mediates VEGF-induced angiogenesis.
    Oncogene. 2008 May 8;27(21):2989-98 PMID: 18059339
  5. Differential regulation of NAB corepressor genes in Schwann cells.
    BMC Mol Biol. 2007 Dec 20;8:117 PMID: 18096076
  6. Multilineage transcriptional priming and determination of alternate hematopoietic cell fates.
    Cell. 2006 Aug 25;126(4):755-66 PMID: 16923394
  7. Redundant role for early growth response transcriptional regulators in thymocyte differentiation and survival.
    J Immunol. 2007 Jun 1;178(11):6796-805 PMID: 17513727
  8. Egr transcription factors in the nervous system.
    Neurochem Int. 1997 Oct;31(4):477-510; discussion 517-6 PMID: 9307998
  9. EGR2 mutations in inherited neuropathies dominant-negatively inhibit myelin gene expression.
    Neuron. 2001 May;30(2):355-68 PMID: 11394999
  10. Active gene repression by the Egr2.NAB complex during peripheral nerve myelination.
    J Biol Chem. 2008 Jun 27;283(26):18187-97 PMID: 18456662
  11. Muscarinic acetylcholine receptors activate expression of the EGR gene family of transcription factors.
    J Biol Chem. 1998 Jun 5;273(23):14538-44 PMID: 9603968
  12. Stress induces zinc finger immediate early genes in the rat adrenal gland.
    Brain Res. 2000 Sep 22;877(2):203-8 PMID: 10986333
  13. Identification of the human PHLDA1/TDAG51 gene: down-regulation in metastatic melanoma contributes to apoptosis resistance and growth deregulation.
    Cancer Res. 2002 Oct 15;62(20):5920-9 PMID: 12384558
  14. Regulation of life and death by the zinc finger transcription factor Egr-1.
    J Cell Physiol. 2002 Dec;193(3):287-92 PMID: 12384981
  15. Interplay of Sp1 and Egr-1 in the proximal platelet-derived growth factor A-chain promoter in cultured vascular endothelial cells.
    J Biol Chem. 1995 Nov 17;270(46):27679-86 PMID: 7499234
  16. Epidermal-growth-factor-induced proliferation of astrocytes requires Egr transcription factors.
    J Cell Sci. 2009 Sep 15;122(Pt 18):3340-50 PMID: 19706684
  17. Novel mutants of NAB corepressors enhance activation by Egr transactivators.
    EMBO J. 1998 Oct 15;17(20):6010-9 PMID: 9774344
  18. Opposing regulation of T cell function by Egr-1/NAB2 and Egr-2/Egr-3.
    Eur J Immunol. 2008 Feb;38(2):528-36 PMID: 18203138
  19. MatInspector and beyond: promoter analysis based on transcription factor binding sites.
    Bioinformatics. 2005 Jul 1;21(13):2933-42 PMID: 15860560
  20. MatInd and MatInspector: new fast and versatile tools for detection of consensus matches in nucleotide sequence data.
    Nucleic Acids Res. 1995 Dec 11;23(23):4878-84 PMID: 8532532
  21. Vascular endothelial growth factor-regulated gene expression in endothelial cells: KDR-mediated induction of Egr3 and the related nuclear receptors Nur77, Nurr1, and Nor1.
    Arterioscler Thromb Vasc Biol. 2003 Nov 1;23(11):2002-7 PMID: 14525795
  22. Early growth responsive gene 3 in human breast carcinoma: a regulator of estrogen-meditated invasion and a potent prognostic factor.
    Endocr Relat Cancer. 2007 Jun;14(2):279-92 PMID: 17639044
  23. Modulation of early growth response (EGR) transcription factor-dependent gene expression by using recombinant adenovirus.
    Gene. 2000 Nov 27;258(1-2):63-9 PMID: 11111043
  24. NAB2, a corepressor of NGFI-A (Egr-1) and Krox20, is induced by proliferative and differentiative stimuli.
    Mol Cell Biol. 1996 Jul;16(7):3545-53 PMID: 8668170
  25. Coordinate expression and distinct DNA-binding characteristics of the four EGR-zinc finger proteins in Jurkat T lymphocytes.
    Immunobiology. 1997 Dec;198(1-3):179-91 PMID: 9442390
  26. Identification of NAB1, a repressor of NGFI-A- and Krox20-mediated transcription.
    Proc Natl Acad Sci U S A. 1995 Jul 18;92(15):6873-7 PMID: 7624335
  27. Hepatocyte growth factor induced up-regulations of VEGF through Egr-1 in hepatocellular carcinoma cells.
    Clin Exp Metastasis. 2009;26(7):685-92 PMID: 19526316
  28. Mader: a novel nuclear protein over expressed in human melanomas.
    Oncogene. 1996 Mar 7;12(5):963-71 PMID: 8649813
  29. Vascular smooth muscle cells express the transcriptional corepressor NAB2 in response to injury.
    Am J Pathol. 1999 Oct;155(4):1311-7 PMID: 10514413
  30. Disruption of Krox20-Nab interaction in the mouse leads to peripheral neuropathy with biphasic evolution.
    J Neurosci. 2008 Jun 4;28(23):5891-900 PMID: 18524893
  31. Frequent and early loss of the EGR1 corepressor NAB2 in human prostate carcinoma.
    Hum Pathol. 2001 Sep;32(9):935-9 PMID: 11567222
  32. NAB2, a corepressor of EGR-1, inhibits vascular endothelial growth factor-mediated gene induction and angiogenic responses of endothelial cells.
    J Biol Chem. 2003 Mar 28;278(13):11433-40 PMID: 12427750
  33. Congenital hypomyelinating neuropathy with lethal conduction failure in mice carrying the Egr2 I268N mutation.
    J Neurosci. 2009 Feb 25;29(8):2312-21 PMID: 19244508
  34. Enhanced EGR1 activity promotes the growth of prostate cancer cells in an androgen-depleted environment.
    J Cell Biochem. 2006 Apr 15;97(6):1292-9 PMID: 16552752
  35. Granulocyte-macrophage colony-stimulating factor and interleukin-3 signaling pathways converge on the CREB-binding site in the human egr-1 promoter.
    Mol Cell Biol. 1994 Sep;14(9):5975-85 PMID: 8065330
  36. Transcription factor EGR3 is involved in the estrogen-signaling pathway in breast cancer cells.
    J Mol Endocrinol. 2004 Jun;32(3):649-61 PMID: 15171706
  37. Egr-1 induces the expression of its corepressor nab2 by activation of the nab2 promoter thereby establishing a negative feedback loop.
    J Biol Chem. 2005 Dec 30;280(52):42785-93 PMID: 16260776
  38. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.
    Methods. 2001 Dec;25(4):402-8 PMID: 11846609
  39. Induction of early growth response-1 mediates microglia activation in vitro but is dispensable in vivo.
    Neuromolecular Med. 2009;11(2):87-96 PMID: 19365618
  40. Impaired prostate tumorigenesis in Egr1-deficient mice.
    Nat Med. 2001 Jan;7(1):101-7 PMID: 11135623
Article Info
Journal
Journal of cellular biochemistry
Abbr.
J Cell Biochem
ISSN
1097-4644
Published
2010-09-01
Pages
207-17
Language
English
Region
United States
NLM ID
8205768
PMCID
PMC2930072
Subset
IM
Grants
NCI NIH HHS · R01 CA106468 · United States
NCI NIH HHS · R01 CA106468-05 · United States
NCI NIH HHS · CA106468 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]